טוען...
Cannabidiol as a potential treatment for psychosis
Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treatment of psychotic disorders and they remain the mains...
שמור ב:
| הוצא לאור ב: | Ther Adv Psychopharmacol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843725/ https://ncbi.nlm.nih.gov/pubmed/31741731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125319881916 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|